Xoft, Inc.
Sunnyvale, CA 94085
Share:
Xoft Reaches Milestone as Axxent-® Electronic Brachytherapy System Is Used to Treat Early Stage Breast Cancer Patients
PHOENIX, May 2 - Bringing improved patient access to a new cancer treatment that is delivered more easily and conveniently, Xoft, Inc. announced that the first breast cancer patients have been treated using the AxxentÃ-® Electronic Brachytherapy System. Designed to help reduce recurrence of breast cancer, the breakthrough new therapy for early stage breast cancer uses a miniaturized X-ray...
Read More »Xoft to Present at the 26th Annual JPMorgan Healthcare Conference
CEO to Provide Update on the Clinical and Commercial Adoption of the AxxentÃ-® Electronic Brachytherapy System FREMONT, Calif., Jan. 3 -- Xoft, Inc., developer of the AxxentÃ-® Electronic Brachytherapy System, a proprietary cancer treatment platform that utilizes X-rays to deliver non-radioactive, isotope-free radiation therapy directly to cancer sites, today announced that it will...
Read More »Xoft Reaches Milestone as Axxent-® Electronic Brachytherapy System Is Used to Treat Early Stage Breast Cancer Patients
PHOENIX, May 2 - Bringing improved patient access to a new cancer treatment that is delivered more easily and conveniently, Xoft, Inc. announced that the first breast cancer patients have been treated using the AxxentÃ-® Electronic Brachytherapy System. Designed to help reduce recurrence of breast cancer, the breakthrough new therapy for early stage breast cancer uses a miniaturized X-ray...
Read More »